Loading...
Integrated Diagnostics Holdings plc
IDGXF•PNK
Healthcare
Medical - Diagnostics & Research
$0.32
$0.00(0.00%)
Integrated Diagnostics Holdings plc (IDGXF) Financial Performance & Statements
Review Integrated Diagnostics Holdings plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
38.74%
↑ 38.74%
Operating Income Growth
64.60%
↑ 64.60%
Net Income Growth
111.14%
↑ 111.14%
Operating Cash Flow Growth
188.52%
↑ 188.52%
Operating Margin
18.18%
↑ 18.18%
Gross Margin
36.77%
↑ 36.77%
Net Profit Margin
17.93%
↑ 17.93%
ROE
23.56%
↑ 23.56%
ROIC
12.81%
↑ 12.81%
Integrated Diagnostics Holdings plc (IDGXF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Integrated Diagnostics Holdings plc stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $5.72B | $4.12B | $3.61B | $5.22B |
| Cost of Revenue | $3.54B | $2.60B | $2.14B | $2.42B |
| Gross Profit | $2.18B | $1.52B | $1.46B | $2.80B |
| Gross Profit Ratio | $0.38 | $0.37 | $0.41 | $0.54 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $533.00M | $401.39M | $359.38M | $316.78M |
| Operating Expenses | $967.21M | $786.59M | $577.70M | $517.35M |
| Total Costs & Expenses | $4.51B | $3.38B | $2.72B | $2.94B |
| Interest Income | $144.68M | $53.48M | $95.37M | $113.18M |
| Interest Expense | $170.57M | $141.69M | $122.68M | $98.003M |
| Depreciation & Amortization | $482.80M | $401.24M | $317.34M | $238.64M |
| EBITDA | $2.09B | $1.28B | $1.29B | $2.57B |
| EBITDA Ratio | $0.37 | $0.31 | $0.41 | $0.50 |
| Operating Income | $1.21B | $737.76M | $1.17B | $2.26B |
| Operating Income Ratio | $0.21 | $0.18 | $0.32 | $0.43 |
| Other Income/Expenses (Net) | $225.25M | -$406000.00 | -$317.80M | -$29.74M |
| Income Before Tax | $1.44B | $737.36M | $853.65M | $2.23B |
| Income Before Tax Ratio | $0.25 | $0.18 | $0.24 | $0.43 |
| Income Tax Expense | $431.22M | $268.99M | $327.06M | $739.82M |
| Net Income | $1.08B | $510.30M | $541.11M | $1.41B |
| Net Income Ratio | $0.19 | $0.12 | $0.15 | $0.27 |
| EPS | $1.82 | $0.85 | $0.90 | $2.35 |
| Diluted EPS | $1.82 | $0.85 | $0.90 | $2.35 |
| Weighted Avg Shares Outstanding | $593.62M | $600.000M | $600.00M | $600.00M |
| Weighted Avg Shares Outstanding (Diluted) | $593.62M | $600.00M | $600.00M | $600.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan